Form 4 for NSPR InspireMD, Inc.
Accepted 2021-11-12 00:00:00 ET · period of report 2021-11-10 · accession 0001493152-21-028168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-12 | 2021-11-10 | NSPR | Shore Craig | CFO, CAO | A - Grant | $0.00 | +73.0K | 118.6K | +160% | $0 |
| D | 2021-11-12 | 2021-11-10 | NSPR | Shore Craig | CFO, CAO | A - Grant | $0.00 | +24.3K | 24.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-10 | A | A | 72,978 | $0.00 | 118,639 | D | — | — | (F1) These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service. |
| 2 | Derivative | Options to purchase common stock (right to buy) | 2021-11-10 | A | A | 24,326 | $0.00 | 24,326 | D | $4.09 · — to 2031-11-10 | 24,326 Common Stock | (F2) The options vest and become exercisable in three equal installments, with 1/3 vesting on each of November 10, 2022, November 10, 2023 and November 10, 2024, subject to the Reporting Person's continued service. |